Skip to main content

Table 4 Odds ratios (ORs) and 95% confidence intervals (CIs) for elevated levels of serum gamma-glutamyltransferase (GGT) by ND2-237 Leu/Met genotype and smoking status

From: NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modifies effects of cigarette smoking on risk of elevated levels of serum liver enzyme in male Japanese health check-up examinees: a cross-sectional study

Genotype and number of cigarettes smoked daily

Frequency

OR (95% CI)

Adjusted OR†(95% CI)

Normal levels of serum GGT

Elevated levels of serum GGT

serum GGT levels < 60 U/L

serum GGT levels ≥ 60 U/L

ND2-237Leu

    

0 (never- or ex-smoker)

96 (64.4)

53 (35.6)

1 (reference)

1 (reference)

1-20

46 (65.7)

24 (34.3)

0.945 (0.520-1.717)

1.142 (0.570-2.291)

>20

22 (68.7)

10 (31.3)

0.823 (0.363-1.868)

1.133 (0.406-3.158)

   

P for trend = 0.648

P for trend = 0.772

ND2-237Met

    

0 (never- or ex-smoker)

68 (68.7)

31 (31.3)

1 (reference)

1 (reference)

1-20

26 (56.5)

20 (43.5)

1.687 (0.820-3.471)

1.926 (0.852-4.351)

>20

10 (40.0)

15 (60.0)

3.289 (1.330-8.138)*

3.030 (1.160-7.918)*

   

P for trend = 0.007

P for trend = 0.019

 

serum GGT levels ≤ 51 U/L

serum GGT levels > 51 U/L

  

ND2-237Leu

    

0 (never- or ex-smoker)

87 (58.4)

62 (41.6)

1 (reference)

1 (reference)

1-20

43 (61.4)

27 (38.6)

0.881 (0.493-1.575)

1.128 (0.556-2.285)

>20

22 (68.7)

10 (31.3)

0.638 (0.282-1.442)

0.823 (0.297-2.280)

   

P for trend = 0.288

P for trend = 0.855

ND2-237Met

    

0 (never- or ex-smoker)

62 (62.6)

37 (37.4)

1 (reference)

1 (reference)

1-20

22 (47.8)

24 (52.2)

1.828 (0.901-3.709)

2.223 (0.994-4.969)

>20

8 (32.0)

17 (68.0)

3.561 (1.400-9.058)**

3.304 (1.220-8.946)*

   

P for trend = 0.004

P for trend = 0.009

  1. †OR adjusted for age, body mass index, habitual alcohol consumption, coffee consumption, antihypertensive treatment and antidiabetic treatment.
  2. *P < 0.05, **P < 0.01.